| Literature DB >> 22778826 |
Abstract
On August 14th, 2009, for the first time, the FDA has approved a psychotropic medication for two indications simultaneously. Saphris (asenapine) is a multitarget atypical antipsychotic medication approved to treat adults with schizophrenia and bipolar I disorder.Entities:
Mesh：
Substances：
Year: 2010 PMID： 22778826 PMCID： PMC3368668 DOI： 10.1021/cn100022a
Source DB: PubMed Journal: ACS Chem Neurosci ISSN： 1948-7193 Impact factor: 4.418